SME Times is powered by   
Search News
Just in:   • GDP data: Economy needs more support  • Sensex jumps 1,100 pts, Nifty at above 9,900  • India's sovereign rating downgraded by Moody's  • Cabinet approves upward revision of MSME definition  • PSBs sanctioned Rs 3,200 cr loans to MSMEs in a single day: Sitharaman 
Last updated: 22 May, 2020  

Tablet.9.Thmb.jpg Hydroxychloroquine trial begins in the UK

Tablet.9.jpg
   Top Stories
» Cabinet approves upward revision of MSME definition
» PSBs sanctioned Rs 3,200 cr loans to MSMEs in a single day: Sitharaman
» Manufacturing output at historic low in May
» Exporters hail exclusion of export turnover, enhancement of turnover limit of MSME
» 'Economic revival may take 6-9 months'
IANS | 21 May, 2020
A trial to see whether two anti-malarial drugs -- chloroquine, hydroxychloroquine -- could prevent the novel coronavirus has begun in the UK's Brighton and Oxford.

The first UK participants in the global trial are being enrolled on Thursday at the Brighton and Sussex University Hospitals and the John Radcliffe Hospital in Oxford, reports the BBC.

They will be given either hydroxychloroquine or a placebo for three months.

These are the first of a planned 25 UK sites, with results expected by the end of the year.

The trial is open to anyone delivering direct care to coronavirus patients in the UK, as long as they have not been diagnosed with COVID-19.

It will test whether the drugs can prevent healthcare workers exposed to the virus from contracting it.

One of the study's leaders, Professor Nicholas White at the University of Oxford said: "We really do not know if chloroquine or hydroxychloroquine are beneficial or harmful against COVID-19."

But, he said, a randomised controlled trial such as this one, where neither the participant nor the researchers know who has been given the drug or a placebo, was the best way to find out.

"A widely available, safe and effective vaccine may be a long way off," the BBC quoted Professor Martin Llewelyn from Brighton and Sussex Medical School, who is also leading the study.

"If drugs as well-tolerated as chloroquine and hydroxychloroquine could reduce the chances of catching COVID-19, this would be incredibly valuable."
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 02 Jun, 2020
  Daily Poll
COVID-19 has directly affected your business
 Yes
 No
 Can't say
  Commented Stories
» Starting an import export business: Basic guide for beginners(1)
» FM reviews macro-economy in FSDC meet(1)
» Appoint distributors, expand your business(1)
» MSME stimulus(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter